نتایج جستجو برای: pah

تعداد نتایج: 7545  

Journal: :Heart 2004
R J Barst L Abenhaim

Exogenous substances such as the appetite suppressant fenfluramine are known to be causally related to the development of pulmonary arterial hypertension (PAH). In these cases, the clinical course as well as the pulmonary vascular disease pathologically is indistinguishable from idiopathic PAH. Other exogenous substances, such as amphetamines, cocaine, and meta-amphetamines, have been considere...

Journal: :Circulation 2016
Evan L Brittain Megha Talati Joshua P Fessel He Zhu Niki Penner M Wade Calcutt James D West Mitch Funke Gregory D Lewis Robert E Gerszten Rizwan Hamid Meredith E Pugh Eric D Austin John H Newman Anna R Hemnes

BACKGROUND The mechanisms of right ventricular (RV) failure in pulmonary arterial hypertension (PAH) are poorly understood. Abnormalities in fatty acid (FA) metabolism have been described in experimental models of PAH, but systemic and myocardial FA metabolism has not been studied in human PAH. METHODS AND RESULTS We used human blood, RV tissue, and noninvasive imaging to characterize multipl...

Journal: :Scientific reports 2016
Dipali Patel Jolanta Kopec Fiona Fitzpatrick Thomas J McCorvie Wyatt W Yue

The multi-domain enzyme phenylalanine hydroxylase (PAH) catalyzes the hydroxylation of dietary I-phenylalanine (Phe) to I-tyrosine. Inherited mutations that result in PAH enzyme deficiency are the genetic cause of the autosomal recessive disorder phenylketonuria. Phe is the substrate for the PAH active site, but also an allosteric ligand that increases enzyme activity. Phe has been proposed to ...

2013
Marc Humbert J Gerry Coghlan Hossein-Ardeschir Ghofrani Friedrich Grimminger Jian-Guo He Gabriela Riemekasten Carmine Dario Vizza Annette Boeckenhoff Christian Meier Janethe de Oliveira Pena Christopher P Denton

BACKGROUND The 12-week, phase III Pulmonary Arterial hyperTENsion sGC-stimulator Trial (PATENT)-1 study investigated riociguat in patients with pulmonary arterial hypertension (PAH). Here, we present a prospectively planned analysis of the safety and efficacy of riociguat in the subgroup of patients with PAH associated with connective tissue disease (PAH-CTD). METHODS Patients with PAH-CTD we...

Journal: :The European respiratory journal 2017
Nermin Diab Paul M Hassoun

Despite the advent of multiple medical therapies for pulmonary arterial hypertension (PAH), there is currently no cure available for this disease which continues to impose a very heavy burden of morbidity and mortality on afflicted patients. Survival on medical therapy is at best 7 years in patients with idiopathic PAH [1] and significantly less in patients with associated PAH (APAH), such as t...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه شهید چمران اهواز 1390

فنیل کتونوری (pku) یک خطای مادرزادی متابولیسم است که از نقص در آنزیم فنیل آلانین هیدروکسیلاز (pah) ناشی می شود. براساس پایگاه اطلاعاتی pahdatabase، اگزو های 6 و 7 ژن pah و نواحی انترونی مجاور آنها بالاترین تعداد آلل های جهش یافته را به خود اختصاص داده اند. بنابراین، در این مطالعه بررسی ترادف اگزون های 6و 7 ژن pah در 25 بیمار فنیل کتونوری استان کرمانشاه انجام گرفت. پیش از این هیچ نوع مطالعه ای د...

Journal: :The Journal of clinical investigation 1988
M J Newman B A Light A Weston D Tollurud J L Clark D L Mann J P Blackmon C C Harris

The presence of serum antibodies to the diol-epoxide DNA adducts of representative polycyclic aromatic hydrocarbons (PAH), chrysene, benz[a]anthracene and benzo[a]pyrene, was determined by ELISA using serum samples obtained from normal healthy individuals. Antibodies that reacted against PAH adducted-DNA, but not against PAH-adducted protein, were found in the serum of approximately 40% of the ...

2013
Alexander von Gise Stephen L. Archer Margaret R. MacLean Georg Hansmann

Pulmonary arterial hypertension (PAH) is characterized by progressive obliteration of pulmonary arterioles leading to increased pulmonary vascular resistance, right heart failure, and death in 30-60% of PAH patients five years after diagnosis. Although PAH is primarily a vascular disease, patients die from right ventricular failure. PAH is a panvasculopathy with key abnormalities evident in the...

2014
Yidan Zhao Jenny Peng Catherine Lu Michael Hsin Marco Mura Licun Wu Lei Chu Ricardo Zamel Tiago Machuca Thomas Waddell Mingyao Liu Shaf Keshavjee John Granton Marc de Perrot

Although multiple gene and protein expression have been extensively profiled in human pulmonary arterial hypertension (PAH), the mechanism for the development and progression of pulmonary hypertension remains elusive. Analysis of the global metabolomic heterogeneity within the pulmonary vascular system leads to a better understanding of disease progression. Using a combination of high-throughpu...

محمدی, حمید, کدیور, الهام, کفیل زاده, فرشید,

Background and Aim: In this research we isolated the bacterial species degrading polycyclic aromatic hydrocarbons (PAHs) and determined optimal salt concentration for PAH degradation.Materials and Methods: We used naphthalene and anthracene as the only sources of carbon for isolating PAH-degrading bacteria the main culture medium was ONR7a. The bacteria isolated by this method were used for the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید